EP0093122A1 - Systemes et procedes de prise de sang a rendement ameliore - Google Patents

Systemes et procedes de prise de sang a rendement ameliore

Info

Publication number
EP0093122A1
EP0093122A1 EP82902864A EP82902864A EP0093122A1 EP 0093122 A1 EP0093122 A1 EP 0093122A1 EP 82902864 A EP82902864 A EP 82902864A EP 82902864 A EP82902864 A EP 82902864A EP 0093122 A1 EP0093122 A1 EP 0093122A1
Authority
EP
European Patent Office
Prior art keywords
primary
blood collection
communication
fluid path
atmosphere
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP82902864A
Other languages
German (de)
English (en)
Other versions
EP0093122A4 (fr
Inventor
Ronald A. Williams
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxter International Inc
Original Assignee
Baxter Travenol Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Travenol Laboratories Inc filed Critical Baxter Travenol Laboratories Inc
Publication of EP0093122A1 publication Critical patent/EP0093122A1/fr
Publication of EP0093122A4 publication Critical patent/EP0093122A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C65/00—Joining or sealing of preformed parts, e.g. welding of plastics materials; Apparatus therefor
    • B29C65/56—Joining or sealing of preformed parts, e.g. welding of plastics materials; Apparatus therefor using mechanical means or mechanical connections, e.g. form-fits
    • B29C65/58—Snap connection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/02—Blood transfusion apparatus
    • A61M1/0209—Multiple bag systems for separating or storing blood components
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
    • A61M39/10—Tube connectors; Tube couplings
    • A61M39/14—Tube connectors; Tube couplings for connecting tubes having sealed ends
    • A61M39/143—Tube connectors; Tube couplings for connecting tubes having sealed ends both tube ends being sealed by meltable membranes pierced after connection by use of heat, e.g. using radiant energy
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C65/00—Joining or sealing of preformed parts, e.g. welding of plastics materials; Apparatus therefor
    • B29C65/02—Joining or sealing of preformed parts, e.g. welding of plastics materials; Apparatus therefor by heating, with or without pressure
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C65/00—Joining or sealing of preformed parts, e.g. welding of plastics materials; Apparatus therefor
    • B29C65/02—Joining or sealing of preformed parts, e.g. welding of plastics materials; Apparatus therefor by heating, with or without pressure
    • B29C65/14—Joining or sealing of preformed parts, e.g. welding of plastics materials; Apparatus therefor by heating, with or without pressure using wave energy, i.e. electromagnetic radiation, or particle radiation
    • B29C65/1429—Joining or sealing of preformed parts, e.g. welding of plastics materials; Apparatus therefor by heating, with or without pressure using wave energy, i.e. electromagnetic radiation, or particle radiation characterised by the way of heating the interface
    • B29C65/1435—Joining or sealing of preformed parts, e.g. welding of plastics materials; Apparatus therefor by heating, with or without pressure using wave energy, i.e. electromagnetic radiation, or particle radiation characterised by the way of heating the interface at least passing through one of the parts to be joined, i.e. transmission welding
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C65/00—Joining or sealing of preformed parts, e.g. welding of plastics materials; Apparatus therefor
    • B29C65/02—Joining or sealing of preformed parts, e.g. welding of plastics materials; Apparatus therefor by heating, with or without pressure
    • B29C65/14—Joining or sealing of preformed parts, e.g. welding of plastics materials; Apparatus therefor by heating, with or without pressure using wave energy, i.e. electromagnetic radiation, or particle radiation
    • B29C65/1477—Joining or sealing of preformed parts, e.g. welding of plastics materials; Apparatus therefor by heating, with or without pressure using wave energy, i.e. electromagnetic radiation, or particle radiation making use of an absorber or impact modifier
    • B29C65/148—Joining or sealing of preformed parts, e.g. welding of plastics materials; Apparatus therefor by heating, with or without pressure using wave energy, i.e. electromagnetic radiation, or particle radiation making use of an absorber or impact modifier placed at the interface
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C65/00—Joining or sealing of preformed parts, e.g. welding of plastics materials; Apparatus therefor
    • B29C65/72—Joining or sealing of preformed parts, e.g. welding of plastics materials; Apparatus therefor by combined operations or combined techniques, e.g. welding and stitching
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C65/00—Joining or sealing of preformed parts, e.g. welding of plastics materials; Apparatus therefor
    • B29C65/74—Joining or sealing of preformed parts, e.g. welding of plastics materials; Apparatus therefor by welding and severing, or by joining and severing, the severing being performed in the area to be joined, next to the area to be joined, in the joint area or next to the joint area
    • B29C65/747—Joining or sealing of preformed parts, e.g. welding of plastics materials; Apparatus therefor by welding and severing, or by joining and severing, the severing being performed in the area to be joined, next to the area to be joined, in the joint area or next to the joint area using other than mechanical means
    • B29C65/7473—Joining or sealing of preformed parts, e.g. welding of plastics materials; Apparatus therefor by welding and severing, or by joining and severing, the severing being performed in the area to be joined, next to the area to be joined, in the joint area or next to the joint area using other than mechanical means using radiation, e.g. laser, for simultaneously welding and severing
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C66/00—General aspects of processes or apparatus for joining preformed parts
    • B29C66/01—General aspects dealing with the joint area or with the area to be joined
    • B29C66/05—Particular design of joint configurations
    • B29C66/10—Particular design of joint configurations particular design of the joint cross-sections
    • B29C66/11—Joint cross-sections comprising a single joint-segment, i.e. one of the parts to be joined comprising a single joint-segment in the joint cross-section
    • B29C66/116—Single bevelled joints, i.e. one of the parts to be joined being bevelled in the joint area
    • B29C66/1162—Single bevel to bevel joints, e.g. mitre joints
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C66/00—General aspects of processes or apparatus for joining preformed parts
    • B29C66/01—General aspects dealing with the joint area or with the area to be joined
    • B29C66/05—Particular design of joint configurations
    • B29C66/10—Particular design of joint configurations particular design of the joint cross-sections
    • B29C66/13—Single flanged joints; Fin-type joints; Single hem joints; Edge joints; Interpenetrating fingered joints; Other specific particular designs of joint cross-sections not provided for in groups B29C66/11 - B29C66/12
    • B29C66/131—Single flanged joints, i.e. one of the parts to be joined being rigid and flanged in the joint area
    • B29C66/1312—Single flange to flange joints, the parts to be joined being rigid
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C66/00—General aspects of processes or apparatus for joining preformed parts
    • B29C66/01—General aspects dealing with the joint area or with the area to be joined
    • B29C66/05—Particular design of joint configurations
    • B29C66/10—Particular design of joint configurations particular design of the joint cross-sections
    • B29C66/13—Single flanged joints; Fin-type joints; Single hem joints; Edge joints; Interpenetrating fingered joints; Other specific particular designs of joint cross-sections not provided for in groups B29C66/11 - B29C66/12
    • B29C66/137—Beaded-edge joints or bead seals
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C66/00—General aspects of processes or apparatus for joining preformed parts
    • B29C66/50—General aspects of joining tubular articles; General aspects of joining long products, i.e. bars or profiled elements; General aspects of joining single elements to tubular articles, hollow articles or bars; General aspects of joining several hollow-preforms to form hollow or tubular articles
    • B29C66/51—Joining tubular articles, profiled elements or bars; Joining single elements to tubular articles, hollow articles or bars; Joining several hollow-preforms to form hollow or tubular articles
    • B29C66/52—Joining tubular articles, bars or profiled elements
    • B29C66/522—Joining tubular articles
    • B29C66/5221—Joining tubular articles for forming coaxial connections, i.e. the tubular articles to be joined forming a zero angle relative to each other
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C66/00—General aspects of processes or apparatus for joining preformed parts
    • B29C66/50—General aspects of joining tubular articles; General aspects of joining long products, i.e. bars or profiled elements; General aspects of joining single elements to tubular articles, hollow articles or bars; General aspects of joining several hollow-preforms to form hollow or tubular articles
    • B29C66/51—Joining tubular articles, profiled elements or bars; Joining single elements to tubular articles, hollow articles or bars; Joining several hollow-preforms to form hollow or tubular articles
    • B29C66/52—Joining tubular articles, bars or profiled elements
    • B29C66/522—Joining tubular articles
    • B29C66/5223—Joining tubular articles for forming corner connections or elbows, e.g. for making V-shaped pieces
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C66/00—General aspects of processes or apparatus for joining preformed parts
    • B29C66/50—General aspects of joining tubular articles; General aspects of joining long products, i.e. bars or profiled elements; General aspects of joining single elements to tubular articles, hollow articles or bars; General aspects of joining several hollow-preforms to form hollow or tubular articles
    • B29C66/51—Joining tubular articles, profiled elements or bars; Joining single elements to tubular articles, hollow articles or bars; Joining several hollow-preforms to form hollow or tubular articles
    • B29C66/52—Joining tubular articles, bars or profiled elements
    • B29C66/522—Joining tubular articles
    • B29C66/5229—Joining tubular articles involving the use of a socket
    • B29C66/52298—Joining tubular articles involving the use of a socket said socket being composed by several elements
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C66/00—General aspects of processes or apparatus for joining preformed parts
    • B29C66/50—General aspects of joining tubular articles; General aspects of joining long products, i.e. bars or profiled elements; General aspects of joining single elements to tubular articles, hollow articles or bars; General aspects of joining several hollow-preforms to form hollow or tubular articles
    • B29C66/51—Joining tubular articles, profiled elements or bars; Joining single elements to tubular articles, hollow articles or bars; Joining several hollow-preforms to form hollow or tubular articles
    • B29C66/53—Joining single elements to tubular articles, hollow articles or bars
    • B29C66/534—Joining single elements to open ends of tubular or hollow articles or to the ends of bars
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C66/00—General aspects of processes or apparatus for joining preformed parts
    • B29C66/50—General aspects of joining tubular articles; General aspects of joining long products, i.e. bars or profiled elements; General aspects of joining single elements to tubular articles, hollow articles or bars; General aspects of joining several hollow-preforms to form hollow or tubular articles
    • B29C66/51—Joining tubular articles, profiled elements or bars; Joining single elements to tubular articles, hollow articles or bars; Joining several hollow-preforms to form hollow or tubular articles
    • B29C66/54—Joining several hollow-preforms, e.g. half-shells, to form hollow articles, e.g. for making balls, containers; Joining several hollow-preforms, e.g. half-cylinders, to form tubular articles
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C66/00—General aspects of processes or apparatus for joining preformed parts
    • B29C66/70—General aspects of processes or apparatus for joining preformed parts characterised by the composition, physical properties or the structure of the material of the parts to be joined; Joining with non-plastics material
    • B29C66/73—General aspects of processes or apparatus for joining preformed parts characterised by the composition, physical properties or the structure of the material of the parts to be joined; Joining with non-plastics material characterised by the intensive physical properties of the material of the parts to be joined, by the optical properties of the material of the parts to be joined, by the extensive physical properties of the parts to be joined, by the state of the material of the parts to be joined or by the material of the parts to be joined being a thermoplastic or a thermoset
    • B29C66/739—General aspects of processes or apparatus for joining preformed parts characterised by the composition, physical properties or the structure of the material of the parts to be joined; Joining with non-plastics material characterised by the intensive physical properties of the material of the parts to be joined, by the optical properties of the material of the parts to be joined, by the extensive physical properties of the parts to be joined, by the state of the material of the parts to be joined or by the material of the parts to be joined being a thermoplastic or a thermoset characterised by the material of the parts to be joined being a thermoplastic or a thermoset
    • B29C66/7392—General aspects of processes or apparatus for joining preformed parts characterised by the composition, physical properties or the structure of the material of the parts to be joined; Joining with non-plastics material characterised by the intensive physical properties of the material of the parts to be joined, by the optical properties of the material of the parts to be joined, by the extensive physical properties of the parts to be joined, by the state of the material of the parts to be joined or by the material of the parts to be joined being a thermoplastic or a thermoset characterised by the material of the parts to be joined being a thermoplastic or a thermoset characterised by the material of at least one of the parts being a thermoplastic
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C66/00—General aspects of processes or apparatus for joining preformed parts
    • B29C66/80—General aspects of machine operations or constructions and parts thereof
    • B29C66/84—Specific machine types or machines suitable for specific applications
    • B29C66/857—Medical tube welding machines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/02—Blood transfusion apparatus
    • A61M1/0209—Multiple bag systems for separating or storing blood components
    • A61M1/0218—Multiple bag systems for separating or storing blood components with filters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
    • A61M39/10—Tube connectors; Tube couplings
    • A61M2039/1027—Quick-acting type connectors
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C35/00—Heating, cooling or curing, e.g. crosslinking or vulcanising; Apparatus therefor
    • B29C35/02—Heating or curing, e.g. crosslinking or vulcanizing during moulding, e.g. in a mould
    • B29C35/08—Heating or curing, e.g. crosslinking or vulcanizing during moulding, e.g. in a mould by wave energy or particle radiation
    • B29C35/0805—Heating or curing, e.g. crosslinking or vulcanizing during moulding, e.g. in a mould by wave energy or particle radiation using electromagnetic radiation
    • B29C2035/0822—Heating or curing, e.g. crosslinking or vulcanizing during moulding, e.g. in a mould by wave energy or particle radiation using electromagnetic radiation using IR radiation
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C2793/00—Shaping techniques involving a cutting or machining operation
    • B29C2793/0045—Perforating
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C65/00—Joining or sealing of preformed parts, e.g. welding of plastics materials; Apparatus therefor
    • B29C65/02—Joining or sealing of preformed parts, e.g. welding of plastics materials; Apparatus therefor by heating, with or without pressure
    • B29C65/04—Dielectric heating, e.g. high-frequency welding, i.e. radio frequency welding of plastic materials having dielectric properties, e.g. PVC
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C65/00—Joining or sealing of preformed parts, e.g. welding of plastics materials; Apparatus therefor
    • B29C65/02—Joining or sealing of preformed parts, e.g. welding of plastics materials; Apparatus therefor by heating, with or without pressure
    • B29C65/14—Joining or sealing of preformed parts, e.g. welding of plastics materials; Apparatus therefor by heating, with or without pressure using wave energy, i.e. electromagnetic radiation, or particle radiation
    • B29C65/1403—Joining or sealing of preformed parts, e.g. welding of plastics materials; Apparatus therefor by heating, with or without pressure using wave energy, i.e. electromagnetic radiation, or particle radiation characterised by the type of electromagnetic or particle radiation
    • B29C65/1412—Infrared [IR] radiation
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C66/00—General aspects of processes or apparatus for joining preformed parts
    • B29C66/50—General aspects of joining tubular articles; General aspects of joining long products, i.e. bars or profiled elements; General aspects of joining single elements to tubular articles, hollow articles or bars; General aspects of joining several hollow-preforms to form hollow or tubular articles
    • B29C66/51—Joining tubular articles, profiled elements or bars; Joining single elements to tubular articles, hollow articles or bars; Joining several hollow-preforms to form hollow or tubular articles
    • B29C66/52—Joining tubular articles, bars or profiled elements
    • B29C66/522—Joining tubular articles
    • B29C66/5224—Joining tubular articles for forming fork-shaped connections, e.g. for making Y-shaped pieces
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C66/00—General aspects of processes or apparatus for joining preformed parts
    • B29C66/70—General aspects of processes or apparatus for joining preformed parts characterised by the composition, physical properties or the structure of the material of the parts to be joined; Joining with non-plastics material
    • B29C66/71—General aspects of processes or apparatus for joining preformed parts characterised by the composition, physical properties or the structure of the material of the parts to be joined; Joining with non-plastics material characterised by the composition of the plastics material of the parts to be joined
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C66/00—General aspects of processes or apparatus for joining preformed parts
    • B29C66/70—General aspects of processes or apparatus for joining preformed parts characterised by the composition, physical properties or the structure of the material of the parts to be joined; Joining with non-plastics material
    • B29C66/73—General aspects of processes or apparatus for joining preformed parts characterised by the composition, physical properties or the structure of the material of the parts to be joined; Joining with non-plastics material characterised by the intensive physical properties of the material of the parts to be joined, by the optical properties of the material of the parts to be joined, by the extensive physical properties of the parts to be joined, by the state of the material of the parts to be joined or by the material of the parts to be joined being a thermoplastic or a thermoset
    • B29C66/739—General aspects of processes or apparatus for joining preformed parts characterised by the composition, physical properties or the structure of the material of the parts to be joined; Joining with non-plastics material characterised by the intensive physical properties of the material of the parts to be joined, by the optical properties of the material of the parts to be joined, by the extensive physical properties of the parts to be joined, by the state of the material of the parts to be joined or by the material of the parts to be joined being a thermoplastic or a thermoset characterised by the material of the parts to be joined being a thermoplastic or a thermoset
    • B29C66/7392—General aspects of processes or apparatus for joining preformed parts characterised by the composition, physical properties or the structure of the material of the parts to be joined; Joining with non-plastics material characterised by the intensive physical properties of the material of the parts to be joined, by the optical properties of the material of the parts to be joined, by the extensive physical properties of the parts to be joined, by the state of the material of the parts to be joined or by the material of the parts to be joined being a thermoplastic or a thermoset characterised by the material of the parts to be joined being a thermoplastic or a thermoset characterised by the material of at least one of the parts being a thermoplastic
    • B29C66/73921—General aspects of processes or apparatus for joining preformed parts characterised by the composition, physical properties or the structure of the material of the parts to be joined; Joining with non-plastics material characterised by the intensive physical properties of the material of the parts to be joined, by the optical properties of the material of the parts to be joined, by the extensive physical properties of the parts to be joined, by the state of the material of the parts to be joined or by the material of the parts to be joined being a thermoplastic or a thermoset characterised by the material of the parts to be joined being a thermoplastic or a thermoset characterised by the material of at least one of the parts being a thermoplastic characterised by the materials of both parts being thermoplastics
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
    • B29K2995/00—Properties of moulding materials, reinforcements, fillers, preformed parts or moulds
    • B29K2995/0018—Properties of moulding materials, reinforcements, fillers, preformed parts or moulds having particular optical properties, e.g. fluorescent or phosphorescent
    • B29K2995/0026—Transparent
    • B29K2995/0027—Transparent for light outside the visible spectrum
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29L—INDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES
    • B29L2031/00—Other particular articles
    • B29L2031/712—Containers; Packaging elements or accessories, Packages
    • B29L2031/7148—Blood bags, medical bags

Definitions

  • This application generally relates to systems and methods which enable the collection and separation of whole blood into its therapeutic components, such as red cells, plasma, platelets, and various clotting factors.
  • This application also generally relates to hole blood collection and separation systems and methods which enable the storage of whole blood and its various therapeutic components for the maximum allowable periods.
  • the clinically proven components of whole blood include red cells, which can be used to treat chronic anemia; platelets, which can be used to treat thrombo-cytopenia? cryoprecipitate, which is rich in Clotting Factor VIII (also known as AHF) and can be used to treat hemophilia; plasma, which can be used to restore all of the clotting factors to patients; as well as numerous other plasma»-based fractions, such as albumin, protein fraction, gamma globulin, and various other specific coagulation protein concentrates.
  • AHF Clotting Factor VIII
  • plasma which can be used to restore all of the clotting factors to patients
  • plasma which can be used to restore all of the clotting factors to patients
  • plasma which can be used to restore all of the clotting factors to patients
  • plasma which can be used to restore all of the clotting factors to patients
  • plasma which can be used to restore all of the clotting factors to patients
  • plasma which can be used to restore all of the clotting factors to patients
  • One desirable feature for a blood collection and separation system and method is its capability to maximize, to the greatest extent possible, the yield of clinically proven blood components during a single collection procedure.
  • the importance of this feature 15 stems in large part from the traditionally limited number of individuals who volunteer to donate whole blood on a regular basis. The importance of this feature also stems from the periodic nature of blood collection procedures themselves. In the United 20 States, for example, a collection of one unit of whole blood from an individual volunteer donor for separation into its various components can be undertaken only once every 8 weeks if the red cells are retained for storage. Maximizing the component 25 yield for each procedure can help to offset these supply-side factors which together limit the supply of available whole blood.
  • Another desirable feature for a blood collection and separation system and method is its 30. capability of yielding components which are suited for storage for prolonged periods. This feature,
  • O * •-T which also helps to offset the limited supply of available whole blood, is closely related to the degree of sterility a given blood collection system can assure.
  • whole blood and components which are collected and processed in a nonsterile, or "open" system must be transfused within twenty-four (24) hours of collection.
  • whole blood and red cells which are collected in a sterile, or "closed” system may be stored for upwards to thirty-five days, depending upon the type of anticoagulant and storage medium used.
  • platelets which are collected in a sterile, or "closed” system may be stored for upwards to five days, depending upon the ability o'f the storage container to maintain proper pH levels.
  • non-sterile entry "opens" a heretofore “closed” system and dictates the significantly shortened storage periods for the blood and components collected and processed within the system.
  • Plasmapheresis is a procedure which facilitates the collection of source plasma for commercial fractionation into AHF, albumin, and other plasma-based protein fractions.
  • a unit of whole blood is collected and separated into red cells and plasma.
  • the red cells are returned to the donor, and the plasma is retained for fractionation purposes.
  • Another unit of whole blood is then drawn from the same donor and again separated into red cells and plasma. Again, the red cells are returned to the donor, and only the plasma is retained.
  • the end result is, for each plasmapheresis procedure, two units of source plasma. Because, during plasmapheresis, no red cells are retained for storage, the plasmapheresis procedure can be repeated twice in a seven day period, allowing the collection of four units of plasma from each donor per week.
  • plasmapheresis assemblies include the following United States Patents: Naftulin 3,459,182 Naftulin et al 3,782,382 Dabney 3,945,380
  • Representative examples of known 5 commercially available plasmapheresis assemblies include those sold by Fenwal Laboratories, Cutter Laboratories; Delmed; and Terumo Company, Ltd., (Japan) .
  • the end result would be, for each plasmapheresis-type procedure, one unit of red cells and two units of plasma and plasma-based components, 5 such as platelets, cryoprecipitate, etc.
  • No known conventional plasmapheresis assembly can be utilized to perform this "increased-yield" procedure and, at the same time, provide blood components which are suited for prolonged storage in the United States.
  • no known conventional plasmapheresis assembly has means for returning the initially collected unit of red cells to the donor in a manner which does not at the same time “open” the system, as judged by the applicable United States standards heretofore discussed.
  • no known conventional plasmapheresis assembly can return the initially collected unit of red cells to the donor with even a probability of nonsterility of one in a' thousand (10- 3), which falls significantly short of the g demanding 10- standard in the United States.
  • One of the principal objects of this invention is to provide a blood collection system and method which maximizes, to the greatest extent possible, the yield of blood components obtained during a single collection procedure in a manner which also assures the maximum available storage period for each of the components collected, as measured by applicable United States standards.
  • yet another desirable feature for a blood collection and separation system and method is that it constitutes a compact and easily handled system which can be efficiently manufactured, stored, and utilized by the operator.
  • it is another one of the principal objects of this invention is to provide a blood collection system which is formed of two or more initially separate, closed subsystems which are compact and easily handled and which can be sequentially joined together without compromising the sterile integrity of any of the subsystems, as measured by applicable United States standards.
  • the invention provides an increased yield blood collection system which maximizes, to the greatest extent possible, the yield of blood components obtained during a single collection procedure in a manner which also assures the maximum permissible storage period for each of the components collected.
  • the system which embodies the features of the invention comprises first and second blood collection assemblies, each of which includes a primary collection container.
  • the first blood collection assembly also includes at least one transfer container which communicates with the associated primary container by means of a fluid path which is closed from communication with the atmosphere.
  • the system further includes primary conduit means which establishes between a phlebotomy needle and each of the primary collection containers a fluid path which is closed from communication with the atmosphere, as well as auxiliary conduit means which establishes between a source of sterile saline and the primary conduit means a fluid path which is likewise closed from communication with the atmosphere.
  • These containers and the conduit means which interconnect them collectively constitute, after sterilization, a "closed" system as measured by applicable standards in the United States.
  • the system includes means for selectively forming a fluid pathway between a selected one of the primary containers and the auxiliary conduit means in a manner which does not compromise the overall closed integrity of the system as measured by applicable standards in the United States.
  • the system includes normally closed first and second connector means which communicate, respectively, with the auxiliary conduit means and the primary container of the first collection assembly.
  • Each of the connector means includes means for selectively mechanically coupling the first and second connector means together with a portion of each in facing contact.
  • the facing portions in turn, each includes means which is meltable to form a fluid path through the facing portions, but only in response to exposure to an energy source sufficient to effectively sterilize the meltable means as the fluid path is being formed.
  • the fluid path which is formed is hermetically closed to communication with the atmosphere. It has been demonstrated that the probability of nonsterility which is occasioned by the formation of this fluid . path exceeds one in a million (10- ), thereby • maintaining the closed integrity of the associated system, as measured by United States Standards.
  • the system as just described enables the an increased yield blood collection method which utilizes a single phlebotomy to sequentially collect two units of whole blood for separation into red cells and plasma.
  • the red cells of the first unit collected are returned to the donor utilizing the just described connector means, with the plasma being retained for further separation and storage.
  • the second unit of whole blood is collected after the red cells from the first unit are returned.
  • the second unit of whole blood is retained in its entirety for storage or for separation and storage .of its components.
  • the invention also provides a blood collection system which is formed of a series of initially separate, compact subsystems which can be selectively joined together by the operator without compromising the sterile integrity of any of the subsystems or the formed system as a whole.
  • the system shares the same basic elements and operative objectives of the heretofore described increased yield blood collection system.
  • the first and second blood collection -assemblies and the primary conduit means together comprise an initially separate, closed first subassembly.
  • th6 auxiliary conduit means likewise comprises another initially separate, closed second subassembly, as does the source of saline.
  • the connector means as heretofore described is associated with each subassembly. Utilizing the connector means, the subassemblies may be selectively coupled together in a manner which does not compromise the closed integrity of any of the subassemblies or of the combined system as a whole.
  • the transfer containers which may be associated with each of the first and second blood collection assemblies of the heretofore described increased yield blood collection system, or, indeed, with any blood collection system, each comprises an initially separate entity which can be selectively coupled in flow communication with the primary collection container utilizing the connector means as above-described.
  • the blood collection system which embodies the features of the invention as described in the preceding two paragraphs comprises a series of individual, closed subsystems. It is thus compact and easily handled by the operator.
  • the system also provides a substantial amount of "in the field” flexibility, so that the operator can readily tailor the specific configuration of the system to the particular collection objectives at hand. All these desirable features are realized without compromise to the desired overall closed integrity of the formed system.
  • Fig. 1 is a perspective view, with a portion broken away and in section, of an increased yield blood collection system which embodies various of the features of the invention
  • Fig. 2 is a perspective view of the increased yield blood collection system shown in Fig. 1 after a first unit of whole blood has been collected from a donor
  • Fig. 3 is a plan view of the increased yield blood collection system shown in Fig. 1 as the red cells of the first unit of whole blood are being returned to the donor;
  • Fig. 4 is a plan view of the increased yield blood collection system shown in Fig. 1 * after the collection of the second unit of whole blood from the donor;
  • Fig. 5 is an enlarged view of a portion of the increased yield blood collection system shown in Fig. 3 prior to the return of the red cells of the first unit of whole blood to the donor;
  • Fig. 6 is a further enlarged view, with portions broken away and in section, of a portion the system shown in Fig. 5, showing the connector means associated with the system in an uncoupled relationship;
  • Fig. 7 is an enlarged view, with portions broken away and in section, of the connector means shown in Fig. 6 in a coupled relationship and being exposed to a radiant energy-induced melting apparatus to open a fluid path therethrough;
  • Fig. 8 is an enlarged view, with portions broken away and in section, of the connector means shown in Fig. 7 after the fluid path has been opened therethrough;
  • Fig. 9 is a plan view of a blood collection system which takes the form of an increased yield blood collection system and which includes a series of initially separate subsystems;
  • Fig. 10 is a plan view of a blood collection system which takes the form of a blood collection assembly and which includes a series of initially separate transfer containers.
  • a blood collection and separation system 10 is shown in Fig. 1. As illustrated, the system 10 includes first and second blood collection and separation assemblies, respectively 12 and 14.
  • the first collection assembly 12 includes a primary container 16 and at least one transfer container 18. While the number of transfer containers provided can vary according to the collection and storage objectives of the operator, in the embodiment illustrated in Fig. 1, three transfer containers 18, 20, and 22 are shown.
  • Branch conduit means 24 establishes a fluid path between the primary container 16 and each of the transfer containers 18, 20, and 22.
  • the branch conduit means 24 is preferably formed of a flexible plastic material suited for blood contact, such as plasticized polyvinyl chloride. As shown in Fig. 1, the branch conduit means
  • the fluid path which is established by the branch conduit means 24 is thereby closed from communication with the atmosphere.
  • the first collection assembly 12 itself thereby constitutes, after sterilization, a closed system as judged by applicable standards in the United States.
  • Fluid communication between the primary container 16 and the first adjacent transfer container 18 is normally closed by a member 26 (shown in phantom lines in Fig. 1) which can be selectively opened by the operator.
  • The* closure member 26 may be variously constructed, and constitute, for example, an external roller clamp. In the illustrated embodiment, however the closure member 26 takes the form of a manually frangible valve member which is located within the fluid path and which can be similar in construction and operation to the valve member disclosed in Carter et al U.S. Patent 4,294,247.
  • the second blood collection assembly 14 also includes a primary container 28. While it is not essential that the second blood collection assembly 14 also include transfer containers, it is usually desirable that one or more transfer containers be provided. Thus, as in the first collection assembly 12, three transfer containers 30, 32, and 34 are provided.
  • branch conduit means 36 establishes a fluid path between the primary container 26 and each of the transfer containers 30, 32, and 34. Also as in the first collection assembly 12, the branch conduit means 36 of the second assembly 14"is formed of a flexible plastic material, such as plasticize . polyvinyl chloride.
  • the branch conduit means 36 of the second collection assembly 13 is integrally connected with each of the transfer containers 30, 32, and 34 as well as with the primary container 28, so that the fluid path which is established by the branch conduit means 36 is closed from communication with the atmosphere.
  • the second collection assembly 14, like the first collection assembly 12, thereby constitutes, after sterilization, a closed system as judged by applicable standards in the United States.
  • Fluid communication between the primary container 28 and the first adjacent transfer container 30 in the second collection assembly 14 is, as in the first collection assembly 12, normally closed by a closure member 38 (shown in phantom lines in Fig. 1).
  • the closure member 38 takes the form of a manually frangible valve member which is disposed within the fluid path and which is identical to the valve member 26 associated with the first collection assembly 12.
  • each of the primary containers 16 and 28 takes the form of a bag made of a plasticized polyvinyl chloride material.
  • other similar materials which are approved for whole blood or red cell contact and storage can be utilized..
  • the transfer containers 18, 20, 22 and 30, 32, 34 may take the form of bags formed of the same plasticized polyvinyl chloride material as the primary containers 16 and 28.
  • the one or more of the transfer containers 18, 20, 22 and 30, 32, 34 may be fabricated of other materials which are known to be beneficial to their intended storage function, as is taught in Smith U. S. Patent 4,222,379.
  • one of the transfer containers may be fabricated from a polyolefin material which is disclosed in Gajewski et al U.S. Patent 4,140,162 and which is suited for prolonged platelet storage because of its gas transmission capabilities.
  • __o:. ⁇ " - '; " ' ° for fractionation purposes may take the form of the container (not shown) which is the subject of Bacehowski et al U.S. Patent 4,253,458.
  • the system 10 further includes primary conduit means 40 for establishing a fluid path between a phlebotomy needle 42 and the primary containers 16 and 28 of each of the blood collection assemblies 12 and 14.
  • the needle 42 includes a removable cover or sheath 44 which normally closes the needle 42 from communication with the atmosphere.
  • the primary conduit means 40 is preferably formed of a flexible plastic material, such as plasticized polyvinyl chloride. As shown in Fig. 1, the primary conduit means 40 is integrally connected with each of the primary containers 16 and 28 and the needle 42, so that the fluid path which -is established by the primary conduit means 40 is closed from communication with the atmosphere. The entire subsystem defined by the primary conduit means 40 and the first and second collection assemblies 12 and 14 thereby constitutes, after sterilization, a closed system as judged by standards in the United States. To prevent blood from clotting during the course of the blood collection procedure, each of the primary containers 16 and 28 is prefilled with a predetermined amount of an anticoagulant solution 46, such as _CD, CPD, or CPDA.
  • an anticoagulant solution 46 such as _CD, CPD, or CPDA.
  • valve means 48 which is situated at the junction of the primary conduit means 40 and each of the primary containers 16 and 28.
  • the valve means 48 serves to retain the desired supply of anticoagulant solution in the containers 16 and 28 prior to use and also acts as a fluid control mechanism during the course of the blood collection procedure.
  • the valve means 48 may be variously constructed, In the illustrated embodiment, however, ' the valve means 48 takes the form of a ball valve which is sealingly lodged in the fluid path and which can be manually squeezed out of the path and into the associated container 16 or 28 to open fluid flow communication at the de-sired time.
  • the system 10 further includes auxiliary conduit means 50 for establishing a fluid path between the primary conduit means 40 and a source 52 of sterile saline or other suitable I.V. solution.
  • the auxiliary conduit means 50 includes an inline filter and drip chamber 54 of conventional construction.
  • the source 52 of sterile saline may be variously constructed.
  • the source 52 includes a bag 55 made of a plasticized polyvinyl chloride material which contains the sterile saline.
  • a bag 55 made of a plasticized polyvinyl chloride material which contains the sterile saline.
  • a suitable overwrap 56 may be provided to prevent evaporation of the saline from the container source 52 during 5 storage.
  • auxiliary conduit means 50 is integrally connected with the saline container 52 as well as with the primary conduit means 40 to thereby form a fluid path 0 which is closed from communication with the atmosphere.
  • a port block assembly 57 is used, such as the one disclosed in Boggs et al, U.S. Patent application Serial Number 282,894, filed July 13, 1981.
  • the auxiliary conduit means 50 and the integrally connected saline container 52 constitute, after sterilization, a closed system as judged by standards in the United States.
  • the auxiliary conduit means 50 is preferably formed of a flexible plastic material, such as plasticized polyvinyl chloride.
  • a member 58 (shown in phantom lines in Fig. 1) normally closes fluid communication between the saline container 52 and the auxiliary conduit means 50 to retain saline in the integrally connected container 52 prior to use.
  • the closure member 58 takes the form of an inline, manually frangible valve member.
  • the system 10 as heretofore described may be sterilized, such as by autoclaving, as a unit.
  • the frangible valve member 58 in the auxiliary conduit means 50 is manually broken.
  • the associated roller clamps 60 and 62 are opened to initially prime the system 10 with saline solution.
  • the roller clamp 62 downstream of the filter and drip chamber 54 is closed. This temporarily isolates the auxiliary conduit means 50 from the primary conduit means 40.
  • the needle cover 44 is removed and a venipuncture is made (see Fig. 2).
  • the closure ball valve member 48 associated with the primary container 16 of the first blood collection assembly 12 is squeezed into the container 16. Whole blood thus flows from the donor through the primary conduit means 40 only into the primary container 16.
  • the primary conduit means 40 upstream of the container 16 is sealed closed.
  • This closure can be accomplished by using a ⁇ paced-apart pair of hand seal clips 64, or by the formation of a hermetic, snap-apart seal using a HEMATRON® dielectric sealer (not shown) sold by the Fenwal
  • the primary conduit means 40 is thereafter severed between the hand seal clips 64 or along the snap-apart seal.
  • the whole blood-filled primary container 16, along with the rest of the first collection assembly 12, is separated from the system 10.
  • the primary container 16 is next placed in a centrifugal device (not shown) or the like to separate the collected unit of whole blood into red cells and platelet-and-cyroprecipitate-rich plasma.
  • the branch conduit means 24 downstream of the first adjacent transfer container 18 is temporarily closed, such as by use of a hemostat 66 (see Fig. 2).
  • the frangible valve member 26 in the branch conduit means 24 upstream of the first adjacent transfer container 18 is opened, and the unit of platelet-and-cyroprecipitate-rich plasma is expressed from the primary container 16 into the first transfer container 18, utilizing known manual or automatic expression methods, leaving behind only red cells in the primary container 16.
  • the branch conduit means 24 between the primary container 16 and transfer container 18 is next sealed closed, again utilizing a pair of hand seal clips 65 or the snap-apart hermetic seal.
  • the branch conduit means 24 is then severed between the clips 65 to separate the primary container 16 from the rest of the first collection assembly 12, i.e., the transfer containers 18, 20, and 22.
  • the platelet-and-cyroprecipitate-rich plasma in the first-utilized transfer container 18 can now be further separated by centrifugation or the like into various therapeutic components.
  • the plasma can be sequentially processed to yield a unit of platelets, a unit of cyroprecipitate, and a unit of source plasma for fractionation purposes.
  • the hemostat 66 (shown in phantom lines in Fig. 3) is sequentially moved along the branch conduit means 24, and these plasma-based components are sequentially transferred from the first transfer container 18 into the other transfer containers 20 and 22.
  • the branch conduit means 24 between the" transfer containers 18, 20, and 22, is sequentially sealed after each transfer as heretofore described to permit separation of the individual transfer containers 18, 20, and 22 for storage.
  • the platelet and cyroprecipitate-rich plasma in the transfer container 18 may itself be frozen for later use without further processing.
  • the system 10 further includes means 67 (see Fig. 3) for establishing a fluid path between the the primary container 16 and the phlebotomy needle 42 in a manner which does not compromise the sterile closed integrity of the system 10 as a whole.
  • the means 67 includes normally closed first and second connector means 68 and 70 which communicate, respectively, with the auxiliary conduit means 50 and the primary container 16.
  • each connector means 68 and 70 includes means 72 for selectively mechanically coupling the first and second connector means 68 and 70 together (as also shown in Figs. 3 and 4) with a
  • the facing portions 74 include means 80 operative for melting to form a fluid path through the connector means 68 and 70, but only in response to exposure to an energy source sufficient in itself to effectively sterilize the means 80 as they melt. This constitutes an active sterilization step which occurs simultaneously with the formation of the fluid path. Furthermore, during the act of melting, the means 80 are preferably operative for fusing together to form a hermetic seal about the periphery of the fluid path. The resulting connection is thus internally sterile and closed from communication with the atmosphere.
  • the connector means 68 and 70 may be variously constructed and employ different means of operation. However, to meet the desired increased-yield objectives of the system 10, the connector means 68 and 70 each must meet certain operative requirements.
  • each connector means 68 and 70 must (1) normally close the associated subassembly from communication with the atmosphere; (2) be opened only in conjunction with an active sterilization step which serves to sterilize the regions adjacent to the fluid path as the fluid path is formed; and (3) be capable of hermetically sealing the fluid path at the time it is formed. It has been determined that the sterile connector generally described in Granzow et al U.S. Patents 4,157,723 and 4,265,280 meets all of the above criteria and, for this reason, such a connector is shown in the illustrated embodiment.
  • each connector means 68 and 70 includes a housing 76 which defines a hollow interior 78 which communicates with its associated part of the system 10.
  • the heretofore described meltable means 80 associated with the facing portions 74 of the connector means 68 or 70 takes the form of meltable wall means, each of which normally seals or closes the associated interior 78 from communication with the atmosphere.
  • the housing 76 further includes a tubular conduit portion 82 which communicates with the interior 78 and which serves to interconnect the connector means 68 and 70 with a length of a tubing, respectively, 84a and 84b.
  • connection means 68 and 70 may be variously attached to the end of the tubing 84, in the illustrated embodiment, a hermetic, friction fit between the tubular conduit portion 82 is envisioned.
  • An elastic band 85 such as made from a latex material, preferably encircles the outer periphery of the junction to assure a fluid tight, hermetic fit between the tubular portion 22 and the respective tubing 84a and b.
  • the tubing 84a associated with the first connector means 68 is integrally connected with the upstream side of the filter and drip chamber 54.
  • a roller clamp 63 is provided to control fluid flow through the tubing 84a in this arrangement.
  • the tubing 84b associated with the second connector means 68 is integrally connected with the primary container 16.
  • an inline valve member 86 (shown in phantom lines in Fig. 5) is provided. While the valve member 86 may be variously constructed, in the illustrated embodiment, it takes the form of an inline frangible valve member 86 like that associated with the saline container 52 and branch conduit means 24 and 36.
  • frangible valve member 86 can form an integral part of the connector housing 76, as is shown in Granzow et al, U.S. Patent 4,265,280.
  • the wall means 80 is fabricated from a radiant energy absorbing material. It is thus operative for melting in response to exposure to a source of radiant energy. Furthermore, the material from which the wall means 80 is constructed is purposefully preselected so that it melts only at temperatures which result in the rapid destruction of any bacterial contaminant on the surface of the material (i.e., over 200 ⁇ C). To permit the transmission of radiant energy through the housing 76 to the meltable wall means 80, the housing 76 is made of a material which does not absorb the particular type of radiant energy selected. In the preferred embodiment, the wall means
  • the material of the wall means 80 is colored black so as to absorb infrared radiation.
  • the housing 76 is made of a clear TPX material which is generally transparent to the passage of infrared radiation.
  • the connecting means 72 takes the form of mating bayonet-type coupling mechanisms, which serve to interlock the connector means 68 and 70 together with their radiant energy absorbing wall means 80 in facing contact (see Fig. 7).
  • a light-induced melting apparatus 90 which, in the illustrated embodiment, consists of an incandescent quartz lamp 91 focused on the opaque, light-absorbing wall means 80, the radiant energy absorbing wall means 80 melt and fuse together, as can be seen in Fig. 8.
  • the wall means 80 form a hermetically sealed opening 88 which establishes through the connector means 68 and 70 a fluid path which is at once sterile and closed to communication with the atmosphere.
  • the utilization of the illustrated connector means 68 and 70 assures a probability of non-sterility which exceeds 10- .
  • Bacillus subtilis var niger (globiguii) spores per milliliter was prepared. This organism was chosen because of its high resistance to dry heat (see Angelotti, et al, "Influence of Spore Masture Content on the Dry Heat Resistance of Bacillus subtilis var niger", Appl. Microbiol., v 16 (5): 735-745, 1968). Eighty (80) uncoupled sterilized connector members (i.e., forty (40) pairs) identical to the connector means 68 and 70 shown in Figs. 5 through 8, were inoculated with 0.01 milliliter of the B_ subtilis var niger (globiguii) suspension.
  • test Connectors Sixteen (16) additional uncoupled and sterilized connector members (i.e., eight (8) pairs) were inoculated only with methanol. Eight (8) of the connectors were each attached to empty, sterile containers, and eight (8) were each attached to sterile containers containing the SCD broth. These will hereafter be referred to as Negative Control
  • Test Connectors were coupled together, forming forty (40) connections between the empty containers and the SCD broth containers.
  • the noninoculated Negative Control Connectors were also coupled together, forming eight (8) connections between the empty containers and the SCD broth containers. Each connection was placed within the light-induced melting apparatus 90 as heretofore described to fuse the membranes together and open a fluid path. The medium was then passed through the connections.
  • the connector means 68 and 70 are joined together (as shown in detail in Fig. 5).
  • the coupled connector means 68 and 70 are next exposed to the source of infrared radiation by utilizing the light-induced melting 90 apparatus (as shown in detail_in Fig. 7).
  • the fluid path 88 is -established which is at once internally sterile and hermetically closed to communication with the atmosphere.
  • the frangible valve member 86 associated with the connector means 70 is broken, and the roller clamps 60, 62, and 63 are opened. Red cells from the primary container 16 of the first collection assembly 12, along with saline, are thereby introduced into the auxiliary conduit means 50 through the. filter and drip chamber 54 for return to the donor.
  • the heretofore opened roller clamp 63 which controls the red cell flow, is closed. Traces of red cells are flushed from the auxiliary and primary conduit means 50 and 40 by the saline.
  • roller clamps 60 and 62 are both closed to terminate the flow of saline into the primary conduit means 40 and to prevent a backflow of fluids from the primary conduit means 40 into the filter and drip chamber 54.
  • the closed ball valve member 48 associated with the primary container 28 of the second collection assembly 14 is squeezed into the container 28, and whole blood again flows
  • the primary conduit means 40 upstream of the second collection assembly 14 is sealed closed by another pair of hand seal clips 69 or the formation of a hermetic, snap-apart seal.
  • the primary conduit means 40 is severed between the* clips 69 to separate the entire second collection assembly 14 from the system 10.
  • the whole blood collected in the primary container 28 is processed into red cells and the other therapeutic components heretofore discussed with regard to the first collection assembly 12.
  • none of the components collected in the second collection assembly 14 is returned to the donor. This terminates the increased yield blood collection and separation procedure utilizing the system 10 shown in Fig. 1.
  • the increased yield collection system 10 permits, during a single procedure, the collection of twice the amount of plasma-based components than can be ordinarily collected utilizing conventional systems and methods. Utilizing the system 10, a blood collection facility can significantly increase its yield of valuable blood components collected without additional donors and without altering the 8-week collection interval in the United States, all with significant savings in time and expense.
  • a therapeutic dose of ten (10) units of platelets, or a comparable therapeutic dose of another component can be collected from five individual donors, instead of ten. Overall collection time and expense per unit of collected component are thus cut in half.
  • the number of more costly and time consuming mobile collections procedures which are conducted away from the blood processing facility, and which require the return of the whole blood collected to the facility for . centrifigation within four hours of collection, can be reduced without adversely effecting the supply of components. Attention is now directed to the blood collection system 11 which is shown in Fig. 9.
  • the system 11 includes separate, closed first, second, and third subassemblies, respectively 5 92, 94 and 96.
  • Each subassembly 92, ' 94, and 96 can be selectively joined by the operator to another subassembly to form the system 11 in a manner which does not compromise the closed integrity of any of the subassemblies 92, 94, 96 or the formed system 11
  • the blood collection system 11 may be variously configured according to the operative objectives desired. As shown in Fig. 9, the illustrated system II generally shares the same basic
  • the first subassembly 92 of the system 11 includes the heretofore described first and second collection assemblies 12 and 14, including connector means 70, and the heretofore described primary conduit means 40 and the phlebotomy
  • the second subassembly 94 of the system 11 includes the heretofore described auxiliary conduit means 50, including connector means 68.
  • the third subassembly 96 of the system 11 includes the ⁇ ource 52 of saline in the form of the bag 55 which is filled with sterile saline and which is carried within a tear-away overwrap 56.
  • Connector means as heretofore described enables the_physical attachment of the subassemblies 92, 94, and 96 one to another, as well as the establishment of interconnecting sterile fluid pathways between the first, second, and third subassemblies 92, 94, and 96, all in a manner which does not compromise the closed integrity of any subassembly 92 or 94 or 96 or the formed system 11 as a whole.
  • the first subassembly 92 includes a single connector means 93; the second subassembly 94 includes a pair of connector means 95 a and b; and the third subassembly 96 includes a single connector means 97.
  • Each of these connector means 93, 95a and b, and 97 is constructed the same as the connector means 68 or 70 heretofore described and shown in Figs. 5 through 8.
  • Each includes the meltable wall means 80 as heretofore described, as well as the mating bayonet-type coupling mechanism 72 for mechanically coupling pairs of the connector means 93, 95a and b, and 97 together to bring the wall means 80 into facing contact.
  • Each connector means 93, 95a and b, and 97 is integrally attached to its associated subassembly 92, 94 and 96 utilizing the same friction fit arrangement which has heretofore been described and which preferably includes the elastic latex band 85.
  • the connector means 93 and 95a can be coupled together to physically join the first subassembly 92 with the second subassembly 94.
  • the connector means 95b and 97 can likewise be coupled together to physically join the second subassembly 94 with the third subassembly 96.
  • the associated wall means 80 will melt and fuse together.
  • Sterile, hermetically sealed fluid pathways will be opened to interconnect each of the various subassemblies 92, 94, and 96 together and form the blood collection system 11.
  • connection C in Fig. 9 by later coupling together connector means--68 and 70 °the ' primary container 16 can be interconnected with the auxiliary conduit means 50 during the course of an increased yield blood collection procedure.
  • the system 11, once formed, can thus be utilized in the same manner as the system 10 heretofore described.
  • the blood collection system 11 in Fig. 9 could also serve to collect source plasma for fractionation purposes. Since it is not essential during the collection of source plasma to maintain the closed integrity of the system 11, in this environment, the connector means 70 associated with the first collection container 16 of the first subassembly 92 could be replaced by a conventional port assembly (not shown) having a normally closed, piercable membrane.
  • the connector means 68 associated with the second subassembly 92 could be replaced by a conventional spike (also not shown) which would serve to puncture the membrane associated with the first collection assembly 12. This would enable the necessary return of red cells from the first collection container 16 to the donor via the second subassembly 92 during the course of the plasmapheresis procedure.
  • the connector means 93 of the first subassembly 92, the connector means 95a and 95b of the second subassembly 94, and the connector means 97 of the third subassembly 96 would all remain as shown in Fig. 9 to enable each of the subassemblies 92, 94, and 96 to be interconnected in the manner heretofore described.
  • the system 13 generally shares the same basic elements and objectives of each of the first and second collection assemblies 12 and 14 heretofore discussed;
  • Fig. 10 shows the system 13 in the configuration of the first collection assembly 12 shown in Figs. 1 and 9, although it should be appreciated that the same arrangement can be utilized for the second collection assembly 14, or virtually any blood collection assembly.
  • the system 13 includes the primary container 16 which is integrally connected with the primary conduit means 40.
  • the primary conduit means 40 can communicate with the system 10 shown in Fig. 1- or the system 11 shown in Fig. 9.
  • the primary conduit means 40 can also constitute a donor tube of a blood collection assembly which is unattached to other blood collection assemblies, such as those sold as single BLOOD-PACK® units by Fenwal Laboratories.
  • the system 13 also includes the branch conduit means 24 heretofore identified.
  • the branch conduit means 24 is configured as a series of interrupted lengths 24a.
  • One interrupted length 24a is integrally connected with the primary container 16, and two interrupted lengths 24a are integrally connected with each transfer container 18, 20, 22.
  • Each interrupted length 24a terminates with a connector means 98 which is constructed the same as the connector means 68 or 70 heretofore discussed.
  • a ⁇ is shown in phantom lines in Fig.
  • the systems 11 and 13 shown, respectively, in Figs. 9 and 10 each provides a blood collection assembly which comprises a series of initially separate subassemblies which can be easily manufactured, packaged, sterilized, shipped, and stored.
  • the assembly so provided gives the operator the flexibility, not found in conventional blood collection assemblies, to conveniently tailor the configuration of the system to meet the collection objectives of the particular procedure.

Landscapes

  • Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Electromagnetism (AREA)
  • Pulmonology (AREA)
  • Optics & Photonics (AREA)
  • Vascular Medicine (AREA)
  • External Artificial Organs (AREA)

Abstract

Systèmes de prise et de séparation de sang (10) comprenant un premier et un deuxième ensembles de prise et de séparation de sang (12, 14). Le premier ensemble de prise (12) comprend un premier récipient (16) et des récipients de transfert (18, 20 et 22). Une conduite de branchement (24) établit un chemin de fluide entre le récipient primaire (16) et chacun des récipients de transfert (18, 20 et 22). Le deuxième ensemble de prise de sang (14) comprend également un récipient primaire (28) et des récipients de transfert (30, 32 et 34). Une conduite de branchement (36) établit un chemin fluide entre le récipient primaire (26) et chacun des récipients de transfert (30, 32 et 34). Le système (10) comprend en outre une conduite primaire (40) servant à établir un passage de fluide entre une aiguille de phlébotomie (42) et les récipients primaires (16, 28). Afin de renvoyer au donneur pendant la procédure une partie des composants sanguins recueillis, le système comprend un assemblage de conduites auxiliaires (50) permettant d'établir un passage de fluide entre le conduit primaire (40) et une source (52) de solution saline stérile. Le système comprend en outre un assemblage connecteur (68, 70) qui sert à former un passage de fluide entre les assemblages de prise de sang (12, 14) et l'assemblage de conduites auxiliaires (5) de manière à pouvoir renvoyer au donneur une partie des composants sanguins recueillis au travers du conduit primaire (4) et de l'aiguille de phlébotomie (42).
EP19820902864 1981-10-30 1982-08-23 Systemes et procedes de prise de sang a rendement ameliore. Withdrawn EP0093122A4 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US31691881A 1981-10-30 1981-10-30
US316918 1981-10-30
US37355582A 1982-04-30 1982-04-30
US373555 1982-04-30

Publications (2)

Publication Number Publication Date
EP0093122A1 true EP0093122A1 (fr) 1983-11-09
EP0093122A4 EP0093122A4 (fr) 1985-07-30

Family

ID=26980661

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19820902864 Withdrawn EP0093122A4 (fr) 1981-10-30 1982-08-23 Systemes et procedes de prise de sang a rendement ameliore.

Country Status (7)

Country Link
EP (1) EP0093122A4 (fr)
JP (1) JPS58501807A (fr)
AR (1) AR229134A1 (fr)
AU (1) AU8952082A (fr)
BR (1) BR8207948A (fr)
ES (1) ES516895A0 (fr)
WO (1) WO1983001573A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU578554B2 (en) * 1986-01-24 1988-10-27 Japanese Red Cross Society Centrifugal method of separating blood components
JP2838725B2 (ja) * 1990-05-02 1998-12-16 テルモ株式会社 血液採取器具
WO2000007642A1 (fr) * 1998-08-07 2000-02-17 Pall Corporation Systeme de traitement de fluides biologiques
FR2825261B1 (fr) 2001-06-01 2003-09-12 Maco Pharma Sa Ligne de prelevement du sang placentaire comprenant une poche de rincage
US20100217179A1 (en) * 2009-02-20 2010-08-26 Baxter International Inc. Bulk delivery peritoneal dialysis system and method
US20210146025A1 (en) * 2019-11-14 2021-05-20 Fenwal, Inc. Methods and Systems for Collecting Whole Blood from a Donor and Maintaining Fluid Volume

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3459182A (en) * 1966-08-08 1969-08-05 Reese Res Found Blood administration method
US3782382A (en) * 1972-02-03 1974-01-01 K N Enterprises Inc Means for blood administration and the like
US4223675A (en) * 1978-07-24 1980-09-23 Baxter Travenol Laboratories, Inc. Solution containers such as blood bags and system for preparing same
BE885343A (fr) * 1979-04-06 1981-01-16 Baxter Travenol Lab Connecteur a membrane etanche en matiere plastique cristalline

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3945380A (en) * 1974-08-21 1976-03-23 Cutter Laboratories, Inc. Plasmapheresis assembly
US4157723A (en) * 1977-10-19 1979-06-12 Baxter Travenol Laboratories, Inc. Method of forming a connection between two sealed conduits using radiant energy
US4332122A (en) * 1978-07-24 1982-06-01 Baxter Travenol Laboratories, Inc. Method of making and filling liquid-containing sterile packages such as blood bags
US4222379A (en) * 1978-10-26 1980-09-16 Baxter Travenol Laboratories, Inc. Multiple blood bag having plasticizer-free portions and a high blood component survival rate
US4265280A (en) * 1979-01-23 1981-05-05 Baxter Travenol Laboratories, Inc. Connector member for sealed conduits

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3459182A (en) * 1966-08-08 1969-08-05 Reese Res Found Blood administration method
US3782382A (en) * 1972-02-03 1974-01-01 K N Enterprises Inc Means for blood administration and the like
US4223675A (en) * 1978-07-24 1980-09-23 Baxter Travenol Laboratories, Inc. Solution containers such as blood bags and system for preparing same
BE885343A (fr) * 1979-04-06 1981-01-16 Baxter Travenol Lab Connecteur a membrane etanche en matiere plastique cristalline

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO8301573A1 *

Also Published As

Publication number Publication date
ES8402220A1 (es) 1984-02-01
JPS58501807A (ja) 1983-10-27
AR229134A1 (es) 1983-06-15
EP0093122A4 (fr) 1985-07-30
AU8952082A (en) 1983-05-18
BR8207948A (pt) 1983-09-20
WO1983001573A1 (fr) 1983-05-11
ES516895A0 (es) 1984-02-01

Similar Documents

Publication Publication Date Title
US4680025A (en) Blood component collection systems and methods
AU651478B2 (en) Systems and methods for removing undesired matter from blood cells
AU680994B2 (en) Blood storage container and method of use
EP0116626B1 (fr) Systeme et procede d'extraction de composants sanguins
US5269946A (en) Systems and methods for removing undesired matter from blood cells
EP0675752B1 (fr) Systeme et methode pour la combinaison de recipients separes contenant un fluide biologique
AU753536B2 (en) Systems and methods for processing and storing placenta/umbilical cord blood
EP0714667B1 (fr) Appareil et méthode d'élimination de matériaux non désirés des cellules sanguines
US5417681A (en) Medical container device and method for manufacturing same
CA2127403A1 (fr) Systeme de pherese
JPH06500042A (ja) 微生物不含長期間貯蔵のため赤血球製品を処理する方法
CA2484195A1 (fr) Appareil et procede de detection de bacteries dans des produits sanguins
CA2104296A1 (fr) Systeme de poches de sang
EP0118473A1 (fr) Systemes et procedes de recuperation de composants du sang a rendement accru
EP0093122A1 (fr) Systemes et procedes de prise de sang a rendement ameliore
WO1984000492A1 (fr) Systemes d'extraction des composants sanguins a ecoulement continu et a rendement accru
EP0113758A1 (fr) Systeme sterile de transfert de fluide et dispositif associe de transfert de fluide a acces multiples
JPS59501537A (ja) 増加収量血液成分採取システムおよび方法
JPH0411224B2 (fr)

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19830607

AK Designated contracting states

Designated state(s): BE CH DE FR GB LI SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19850301

RIN1 Information on inventor provided before grant (corrected)

Inventor name: WILLIAMS, RONALD A.